Fundraising FoxISA Pharmaceuticals
3 known investors
Find your way into ISA Pharmaceuticals
Sign up to see every warm intro you have to ISA Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ISA Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Netherlands-based developer of fully synthetic immune therapies against cancer and persistent viral infections using a synthetic long peptide platform.
Investors · 3
Funding
SEC filings, press & company announcements$5M disclosed across 1 of 2 rounds · 2021–2023
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does ISA Pharmaceuticals do?
- Netherlands-based developer of fully synthetic immune therapies against cancer and persistent viral infections using a synthetic long peptide platform.
- Who are ISA Pharmaceuticals's investors?
- ISA Pharmaceuticals's investors include Cancer Focus, Invest-NL, Regeneron Ventures.
- How much funding has ISA Pharmaceuticals raised?
- ISA Pharmaceuticals has disclosed $5M raised across 1 of its 2 known rounds.